Company Filing History:
Years Active: 2003-2005
Title: The Innovations of Wenlin Zeng
Introduction
Wenlin Zeng is a notable inventor based in Union City, CA. He has made significant contributions to the field of signal transduction and genetic research. With a total of 2 patents, his work has implications for the treatment and understanding of various diseases, particularly cardiac conditions.
Latest Patents
Wenlin Zeng's latest patents include innovative approaches to signal transduction. One patent focuses on polypeptides that regulate signal transduction, which may exhibit kinase activity. These polypeptides, or antibodies against them, can be utilized in the identification, prevention, or treatment of diseases, especially cardiac diseases in mammals. Additionally, these polypeptides can aid in identifying or isolating other mediators of signal transduction associated with cardiac diseases. His second patent involves methods for isolating naked cuticle genes. These nucleic acid compositions are useful for identifying related proteins and their encoding DNA sequences. They also facilitate the modulation of gene activity for therapeutic purposes, such as identifying cell types based on expression.
Career Highlights
Wenlin Zeng has worked at prestigious institutions, including Leland Stanford Junior University and Scios Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and genetics.
Collaborations
Throughout his career, Wenlin Zeng has collaborated with notable individuals, including Matthew Peter Scott and Keith Wharton. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Wenlin Zeng's contributions to the field of signal transduction and genetic research highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving health outcomes.